Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome : a systematic review of randomised controlled trials and network meta-analysis

Tools
- Tools
+ Tools

Armoiry, Xavier, Kanda, Akira, Melendez-Torres, G. J., Court, Rachel A., Sutcliffe, P. (Paul), Auguste, Peter, Madan, Jason, Counsell, C. and Clarke, Aileen (2018) Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome : a systematic review of randomised controlled trials and network meta-analysis. Journal of Neurology, 265 (5). pp. 999-1009. doi:10.1007/s00415-018-8752-8 ISSN 0340-5354.

[img]
Preview
PDF
WRAP-short-long-term-clinical-beta-interferon-acetate-isolated-syndrome-Armoiry-2018.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (2113Kb) | Preview
[img] PDF
WRAP-short-long-term-beta-interferon-clinically-syndrome-trials-meta-anlysis-Armoiry-2018.pdf - Accepted Version
Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer.

Download (792Kb)
Official URL: http://dx.doi.org/10.1007/s00415-018-8752-8

Request Changes to record.

Abstract

BACKGROUND:
Beta-interferon (IFN-β) and glatiramer acetate (GA) have been evaluated in people with clinically isolated syndrome (CIS) with the aim to delay a second clinical attack and a diagnosis of clinically definite multiple sclerosis (CDMS). We systematically reviewed trials evaluating the short- and long-term clinical effectiveness of these drugs in CIS.

METHODS:
We searched multiple electronic databases. We selected randomised controlled studies (RCTs) conducted in CIS patients and where the interventions were IFN-β and GA. Main outcomes were time to CDMS, and discontinuation due to adverse events (AE). We compared interventions using random-effect network meta-analyses (NMA). We also reported outcomes from long-term open-label extension (OLE) studies.

RESULTS:
We identified five primary studies. Four had open-label extensions following double-blind periods comparing outcomes between early vs delayed DMT. Short-term clinical results (double-blind period) showed that all drugs delayed CDMS compared to placebo. Indirect comparisons did not suggest superiority of any one active drug over another. We could not undertake a NMA for discontinuation due to AE. Long-term clinical results (OLE studies) showed that the risk of developing CDMS was consistently reduced across studies after early DMT treatment compared to delayed DMT (HR = 0.64, 95% CI 0.55, 0.74). No data supported the benefit of DMTs in reducing the time to, and magnitude of, disability progression.

CONCLUSIONS:
Meta-analyses confirmed that IFN-β and GA delay time to CDMS compared to placebo. In the absence of evidence that early DMTs can reduce disability progression, future research is needed to better identify patients most likely to benefit from long-term DMTs.

Item Type: Journal Article
Subjects: R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Multiple sclerosis -- Diagnosis, Neurology, Systematic reviews (Medical research), Clinical trials
Journal or Publication Title: Journal of Neurology
Publisher: Springer Medizin
ISSN: 0340-5354
Official Date: May 2018
Dates:
DateEvent
May 2018Published
22 January 2018Available
12 January 2018Accepted
Volume: 265
Number: 5
Page Range: pp. 999-1009
DOI: 10.1007/s00415-018-8752-8
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 1 February 2018
Date of first compliant Open Access: 11 April 2018
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
ID809Health Technology Assessment programmehttp://dx.doi.org/10.13039/501100000664
UNSPECIFIEDNational Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us